As support for this, the efficacy of anti-IL-6 receptor antibodies have been recently reported to be effective against BD not only in TNF inhibitor naive patients, but even in TNF inhibitor-experienced patients (49, 50). The gene discussed is TNF; the disease is Behcet disease.